Cargando…
Risk factors for renal toxicity after inpatient cisplatin administration
BACKGROUND: After several decades, cisplatin continues to be an essential drug for the treatment of several tumors, however, its potential nephrotoxicity is still a clinically relevant issue. Identification of predisposing factors for renal toxicity could be of value to warrant prophylactic measures...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052961/ https://www.ncbi.nlm.nih.gov/pubmed/32122396 http://dx.doi.org/10.1186/s40360-020-0398-3 |